Palo Alto Networks insider files Form 144 to sell 300k shares via J.P. Morgan
Rhea-AI Filing Summary
Palo Alto Networks (PANW) Form 144 summary: An insider proposes to sell 300,000 shares of common stock through J.P. Morgan Securities, with an approximate aggregate market value of $61,086,000, planned for 10/01/2025 on NASDAQ. The shares were originally acquired as founder shares by Nir Zuk on 03/07/2005. The filing shows prior sales by the Hawk Family Trust of 100,000 shares on 08/01/2025 and 100,000 shares on 09/02/2025, each generating gross proceeds of $17,280,459. The filing includes the required representation that the seller does not possess undisclosed material adverse information.
Positive
- None.
Negative
- Form 144 discloses a proposed sale of 300,000 PANW shares with an aggregate market value of $61,086,000 planned for 10/01/2025.
- The filing shows two recent sales by the Hawk Family Trust totaling 200,000 shares (100,000 on 08/01/2025 and 100,000 on 09/02/2025) with gross proceeds of $17,280,459 each.
Insights
TL;DR: Insider founder plans to sell 300,000 PANW shares (~$61.1M) on 10/01/2025; prior trust sales totaled 200,000 shares.
This Form 144 documents a proposed sale of 300,000 Palo Alto Networks common shares via J.P. Morgan Securities with an aggregate market value reported at $61,086,000. The seller acquired the shares as founder shares on 03/07/2005. The filing also reports two recent sales by the Hawk Family Trust totaling 200,000 shares in August and September 2025, each yielding $17,280,459. The proposed sale size represents a small fraction of the reported 668,900,000 outstanding shares, but the dollar value is material on an absolute basis. The filing is procedural under Rule 144 and includes the standard attestation regarding material nonpublic information.
TL;DR: Form 144 discloses founder-originated shares offered for sale and recent trust dispositions; filing fulfills Rule 144 notice requirements.
The document indicates the shares were originally issued to an identified founder in 2005 and are being sold through an institutional broker on an indicated date. It also records two recent trust sales with stated gross proceeds. The filing contains the required seller representation about the absence of undisclosed material adverse information. This is a routine regulatory disclosure enabling public sale under Rule 144 rather than a corporate action or amendment to company governance documents.